A regional-West Midlands audit on implementing the neo-adjuvant chemoimmunotherapy (NACIO) pathway for resectable non-small cell Cancer (NSCLC) patients

被引：0
|
作者：
Chaudhary, Prabhav [1 ]
Budacan, Alina [1 ]
Jegannathen, Apurna [1 ]
Srinivasan, Lakshmi [1 ]
Mahendran, Kajan [1 ]
Ghosh, Ghosh [1 ]
Abah, Udo [1 ]
Sivaramalingam, Muthiah [1 ]
Jesani, Hannah [2 ]
Wotton, Robin [3 ]
机构：
[1] Royal Stoke Univ Hosp, Stoke On Trent, England
[2] Univ Hosp Coventry & Warwickshire, Coventry, England
[3] Queen Elizabeth Hosp Birmingham, Birmingham, England
来源：
LUNG CANCER | 2025年 / 200卷
关键词：
D O I：
10.1016/j.lungcan.2025.108203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R
    Lee, J
    Han, J
    Tsai, C
    Boyer, M
    Mok, T
    Kim, S
    Lee, J
    Brnabic, A
    Lehnert, M
    LUNG CANCER, 2005, 49 : S92 - S92
  • [22] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC).
    Abratt, RP
    Lee, JS
    Han, JY
    Tsai, CM
    Boyer, M
    Mok, T
    Kim, SW
    Lee, JS
    Brnabic, AJM
    Lehnert, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [23] Phase II trial of neo-adjuvant gemeltabine-carboplatin-paclitaxel (GCP) chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R. P.
    Lee, J. S.
    Han, J. Y.
    Tsai, C. M.
    Boyer, M.
    Mok, T.
    Kim, S. W.
    Lee, J. S.
    Brnabic, A. J. M.
    Lehnert, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 339 - 339
  • [24] Adjuvant Chemotherapy/Radiotherapy Rates in Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cheung, Francis
    Goldblatt, Joshua
    Alam, Naveed
    Wright, Gavin
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S223 - S224
  • [25] NEO-ADJUVANT CHEMOTHERAPY AND RADIATION THERAPY IN PATIENTS WITH STAGE IIIA (N2) NON-SMALL CELL LUNG CANCER (NSCLC). A RETROSPECTIVE ANALYSIS WITH LESSONS LEARNED
    Friedman, Eliot
    Szwerc, Michael
    Andrews, Charles
    Kruklitis, Robert
    Santiago, Ferdy
    Leies, Kathleen
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1575 - S1575
  • [26] Adjuvant chemotherapy for resected non-small cell lung cancer (NSCLC): the West of Scotland Experience
    Slater, S.
    Nowicki, S.
    Brown, J.
    Steele, N.
    LUNG CANCER, 2012, 75 : S11 - S11
  • [27] Dynamic Monitoring Before and After Neo-Adjuvant Crizotinib in Non-Small Cell Lung Cancer: A Brief Report
    Zhang, C.
    Chen, Y.
    Dong, S.
    Nie, Q.
    Yang, J. -
    Yang, X.
    Zhang, X.
    Wu, Y.
    Zhong, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S865 - S865
  • [28] A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC).
    Owen, Dwight Hall
    Bunn, Paul A.
    Johnson, Bruce E.
    Kwiatkowski, David J.
    Kris, Mark G.
    Wistuba, Ignacio Ivan
    Gandhi, Mayank
    Phan, See
    Shames, David S.
    Schulze, Katja
    Yu, Wei
    Aisner, Dara
    Chaft, Jamie E.
    Garon, Edward B.
    Lee, Jay M.
    Minna, John D.
    Rusch, Valerie W.
    Reckamp, Karen L.
    Wozniak, Antoinette J.
    Carbone, David P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
    Chen, Yulong
    Zhang, Lianmin
    Yan, Bo
    Zeng, Ziqing
    Hui, Zhenzhen
    Zhang, Ran
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 761 - 767
  • [30] Pathological response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and meta-analysis.
    Syaj, Sebawe
    Akhdar, Marah
    Ababneh, Obada Ehab
    Hamouri, Shadi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345